326 related articles for article (PubMed ID: 21681689)
1. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Yokoyama Y; Xin B; Shigeto T; Mizunuma H
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
Shigeto T; Yokoyama Y; Xin B; Mizunuma H
Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
[TBL] [Abstract][Full Text] [Related]
4. Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer.
Yokoyama Y; Xin B; Shigeto T; Umemoto M; Kasai-Sakamoto A; Futagami M; Tsuchida S; Al-Mulla F; Mizunuma H
Mol Cancer Ther; 2007 Apr; 6(4):1379-86. PubMed ID: 17431116
[TBL] [Abstract][Full Text] [Related]
5. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.
Li W; Wan L; Zhai LY; Wang J
Int J Mol Sci; 2014 Oct; 15(10):19265-80. PubMed ID: 25342321
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice.
Hirakawa H; Yokoyama Y; Yoshida H; Mizunuma H
J Ovarian Res; 2014 Jan; 7():4. PubMed ID: 24410765
[TBL] [Abstract][Full Text] [Related]
7. Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
Hazra S; Dubinett SM
Prostaglandins Leukot Essent Fatty Acids; 2007 Jul; 77(1):51-8. PubMed ID: 17697767
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
[TBL] [Abstract][Full Text] [Related]
9. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
Li W; Xu RJ; Lin ZY; Zhuo GC; Zhang HH
Med Oncol; 2009; 26(2):170-7. PubMed ID: 18988002
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
[TBL] [Abstract][Full Text] [Related]
11. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Li D; Williams JI; Pietras RJ
Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
[TBL] [Abstract][Full Text] [Related]
12. Ciglitazone enhances ovarian cancer cell death via inhibition of glucose transporter-1.
Shin SJ; Kim JY; Kwon SY; Mun KC; Cho CH; Ha E
Eur J Pharmacol; 2014 Nov; 743():17-23. PubMed ID: 25240713
[TBL] [Abstract][Full Text] [Related]
13. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
[TBL] [Abstract][Full Text] [Related]
14. Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma.
Shaik MS; Chatterjee A; Singh M
Clin Cancer Res; 2004 Feb; 10(4):1521-9. PubMed ID: 14977856
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with the Cox-2 inhibitor niflumic acid and PPARγ ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells.
Kim BM; Maeng K; Lee KH; Hong SH
Cancer Lett; 2011 Jan; 300(2):134-44. PubMed ID: 21067863
[TBL] [Abstract][Full Text] [Related]
16. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway.
Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
J Biol Chem; 2007 Feb; 282(8):5356-66. PubMed ID: 17186945
[TBL] [Abstract][Full Text] [Related]
17. The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.
Plissonnier ML; Fauconnet S; Bittard H; Lascombe I
PLoS One; 2011; 6(12):e28354. PubMed ID: 22174792
[TBL] [Abstract][Full Text] [Related]
18. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
Dong YW; Wang XP; Wu K
World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448
[TBL] [Abstract][Full Text] [Related]
19. The potent peptide antagonist to angiogenesis, C16Y, and cisplatin act synergistically in the down-regulation of the Bcl-2/Bax ratio and the induction of apoptosis in human ovarian cancer cells.
Shinagawa A; Yoshida Y; Kurokawa T; Horiuchi Y; Tsuyoshi H; Orisaka M; Sawamura Y; Kleinman HK; Kotsuji F
Int J Oncol; 2011 Dec; 39(6):1359-64. PubMed ID: 21935568
[TBL] [Abstract][Full Text] [Related]
20. [Avastin combined with cisplan inhibits malignant ascites production in nude mice bearing transplanted ovary carcinoma with high VEGF expression].
Cai YJ; Zheng DY; Luo RC; Chen JZ; Li AM; Xi JL; Ding XM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):647-9. PubMed ID: 17545079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
